Botulinum toxin – a new method in long-term prevention of recurring atrial fibrillation

iStock_000055110862_XXXLargeBotulinum toxin (botox, BTX) and bacteria which produce it were identified for the first time in 1897 by Belgian bacteriologist Emile Pierre van Ermenghen [1]. Although many decades have passed since this historical moment, its “hidden” properties are still an unsolved mystery. However, already today it can be said that botulinum toxin is an amazing substance. The best evidence of that are results of research published on 20th October 2015 in American magazine Circulation: Arrhythmia and Electrophysiology. On the basis of conducted randomized study it was shown that in the nearest future botulinum toxin may be used on a large scale in long-term prevention of paroxysmal atrial fibrillation recurrence (PAF), especially in patients after cardiac surgeries [2]. Read full text »